期刊文献+

脂蛋白脂酶Ser447Stop基因多态与脑梗死的相关性 被引量:3

Association study of fipoprotein lipase Ser447Stop polymorphisms with acute ischemic stroke
原文传递
导出
摘要 目的探讨脂蛋白脂酶(LPL)Ser447Stop基因多态与脑梗死的相关性。方法受试者共883人,其中脑梗死组563例[包括动脉粥样硬化(AS)性脑梗死329例和腔隙性脑梗死234例],对照组320名,应用聚合酶链反应-限制性片段长度多态性方法,对LPL基因Ser447Stop位点进行基因多态性检测。结果脑梗死组、AS性脑梗死组和腔隙性脑梗死组LPL Ser447Stop GG+CG基因型频率与对照组相比,差异无统计学意义,AS性脑梗死组G变异等位基因频率(64例,9.7%)与对照组(42例,6.6%)相比差异有统计学意义(x^2=3.99,P=0.045)。相对于C等位基因,G等位基因的OR值为1.510(95%CI1.012—2.261)。结论LPL Ser447Stop G变异等位基因携带者患AS性脑梗死的危险高于非携带者。G变异等位基因可能是AS性脑梗死高危险性的遗传标志之一。 Objective To investigate the genetic association between polymorphisms of Ser447Stop in lipoprotein lipase (LPL) gene and ischemic stroke. Methods A case-control study was performed in 563 acute ischemic stroke patients and 320 controls. LPL Ser447Stop genotypes in the subjects were detected by polymerase chain reaction and restriction fragment length polymorphism assay. The frequencies of the alleles in each group were statistically analyzed with Student t-test. Results No significant difference was found in the frequency of G allele of LPL Ser447Stop polymorphism between the case and the control. When subjects were divided into 2 subgroups of cerebral thrombosis infarction and lacunar infarction, the frequency of G allele was significantly higher in the cerebral thrombosis infarction group (9.7%) than that in the control (6. 6%, X^2 = 3.99, P =0. 045), and an increased risk for thrombosis infarction was suggested in the G allele ( OR = 1. 510, 95% CI 1. 012-2. 261 ). Conclusion The G allele in polymorphysim Ser447Stop in LPL may be associated with increased risk of cerebral thrombosis infarction.
出处 《中华神经科杂志》 CAS CSCD 北大核心 2009年第3期175-178,共4页 Chinese Journal of Neurology
基金 吉林省科技厅资助项目(20060413-1) 长春市科技局资助项目(2006070)
关键词 脑梗死 脂蛋白脂酶 多态性 单核苷酸 Brain infarction Lipoprotein lipase Polymorphism, single nucleotide
  • 相关文献

参考文献10

  • 1Dominiczak AF, McBride MW. Genetic of common polygenic stroke. Nat Genet, 2003, 35:116-117.
  • 2各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33022
  • 3Goldberg IJ, Merkel M. Lipoprotein lipase : physiology, biochemistry, and molecular biology. Front Biosci, 2001, 6: D388-405.
  • 4Mamputu JC, Levesque L, Renier G. Proliferative effect of lipoprotein lipase on human vascular smooth muscle ceils. Arterioscler Thromb Vasc Biol, 2000, 20:2212-2219.
  • 5官国东,徐恩,王小娟,许寅宏,邱少东.脂蛋白脂酶Ser447Ter基因多态性与动脉硬化性脑梗死的相关研究[J].中华医学遗传学杂志,2006,23(5):519-522. 被引量:6
  • 6Mead JR, Irvine SA, Ramji DP. Lipoprotein lipase structure, function, regulation, and role in disease. J Mol Med, 2002,80 : 753 -769.
  • 7Myllykangas L, Polvikoski T, Sulkava R, et al. Association of lipoprotein lipase Ser447Ter polymorphism with brain infarction: a population-based neuropathological study. Ann Med, 2001, 33 : 486-492.
  • 8Shimo-Nakanishi Y, Urable T, Hattori N, et al. Polymorphism of the lipoprotein lipase gene and risk of a themthrombotic cerebral infarction in the Japanese. Stroke, 2001, 32 : 1481-1486.
  • 9Morrison AC, Ballantyne CM, Bray M, et al. LPL polymorphism predicts stroke risk in men. Genet Epidemiol, 2002, 22: 233- 242.
  • 10Baum L, Ng HK, Wong KS, et al. Associations of apolipoprotein E exon 4 and lipoprotein lipase S447X polymorphisms with acute ischemic stroke. Clin Chem Lab Med, 2006,dd :274-281.

二级参考文献14

  • 1Mead JR, Irvine SA, Ramji DP. Lipoprotein lipase: structure, function,regulation, and role in disease. J Mol Med, 2002, 80:753-769.
  • 2Goldberg IJ, Merkel M. Lipoprotein lipase: physiology, biochemistry, and molecular biology. Front Biosci, 2001,6: D388-405.
  • 3Zhao SP, Tong QG, Xiao ZJ, et al. The lipoprotein lipase Ser447Ter mutation and risk of stroke in the Chinese. Clin Chim Acta, 2003, 330:161-164.
  • 4Mamputu JC, Levesque L, Renier G. Proliferative effect of lipoprotein lipase on human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol, 2000, 20:2212-2219.
  • 5Chen W, Srinivasan SR, Elkasabany A, et al. Influence of lipoprotein lipase serine 447 stop polymorphism on tracking of triglycerides and HDL cholesterol from childhood to adulthood and familial risk of coronary artery disease: the Bogalusa heart study. Atherosclerosis, 2001,159: 367-373.
  • 6Hendemon HE, Kastelein JJ, Zwinderman AH, et al. Lipoprotein lipase activity is decreased in a large cohort of patients with coronary artery disease and is associated with changes in lipids and lipoproteins. J Lipid Res,1999,40: 735-743.
  • 7Zhang H, Henderson H, Gagne SE, et al. Common sequence variants of lipoprotein lipase: standardized studies of in vitro expression and catalytic function. Biochim Biophys Acta, 1996, 1302: 159-166.
  • 8Skoglund-Andersson C, Ehrenborg E, Fisher RM, et al. Influence of common variants in the CETP, LPL, HL and APO E genes on LDL heterogeneity in healthy, middle-aged man. Atherosclerosis, 2003,167: 311-317.
  • 9David J, Matthew R, Robert A, et al. Lipoprotein lipase (LPL) gene variation and progression of carotid artery plaque. Stroke, 2003,34:1176-1180.
  • 10Shimo-Nakamshi Y, Urabc T, Hattori N, et al. Polymorphism of the lipoprotein lipase gene and risk of atherothrombotic cerebral infarction in the Japanese. Stroke, 2001,32: 1481-1486.

共引文献33026

同被引文献28

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部